ZeroStack Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de ZeroStack han disminuido a una tasa media anual de -30.4%, mientras que en la industria Healthcare los beneficios crecieron en un 11.6% anualmente. Los ingresos han ido creciendo a una tasa media de 15.2% al año.
Información clave
-30.45%
Tasa de crecimiento de los beneficios
46.13%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 8.50% |
| Tasa de crecimiento de los ingresos | 15.16% |
| Rentabilidad financiera | -1,265.05% |
| Margen neto | -436.65% |
| Última actualización de beneficios | 30 Jun 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.FLGC: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Flora Growth from $20.50 to $11.00, citing updated assumptions that now reflect a steeper projected revenue decline of 24.87% along with a slightly lower discount rate and essentially unchanged profit margin and future P/E inputs. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp.Flora Growth Corp. (NASDAQ:FLGC) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 26% in the...FLGC: Forward Share Split And Preferred Share Authorization Will Drive Upside
Analysts now place their price target for Flora Growth at US$20.50, unchanged from the prior US$20.50. They cite only marginal tweaks to inputs, such as a slightly lower discount rate, while keeping revenue growth and profit margin expectations effectively stable.FLGC: Forward Share Split And Preferred Shares Will Support Upside Potential
Analysts have modestly raised their price target on Flora Growth, increasing the estimate by $0.00 to reflect a slightly higher perceived risk profile driven by an uptick in the discount rate, while keeping long term growth and profitability expectations essentially unchanged. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp., create a new class of preferred shares, and implement a forward share split of between 2:1 and 10:1.FLGC: Forward Share Split And New Capital Raising Will Fuel Upside Potential
Analysts have modestly raised their price target on Flora Growth to $20.50, citing a slightly lower perceived risk reflected in a reduced discount rate, while maintaining stable expectations for revenue growth and profit margins. What's in the News Flora Growth has convened a special shareholders meeting for December 19, 2025 in Toronto to vote on corporate actions including capital structure and governance items (company filing).FLGC: Forward Share Split and Equity Offering Will Drive Renewed Momentum
Analysts have significantly lowered their price target for Flora Growth from $93.00 to $20.50. They cite revised expectations for revenue growth and a slightly reduced discount rate as key factors influencing this adjustment.Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 26% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...US Cannabis And European Beverage Markets Will Create Opportunities
Flora Growth’s consensus Analyst Price Target was notably reduced from $156.00 to $93.00 due to continued gross margin pressure, underwhelming operational progress despite a strategic shift toward branded U.S. and European opportunities, and softer-than-expected recent results, although long-term confidence in management’s direction remains. Analyst Commentary Gross margin pressure negatively impacted Flora Growth's bottom line results this quarter.Investors Aren't Buying Flora Growth Corp.'s (NASDAQ:FLGC) Revenues
Flora Growth Corp.'s ( NASDAQ:FLGC ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now...
US Cannabis And European Beverage Markets Will Create Opportunities
Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry.Is Flora Growth (NASDAQ:FLGC) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Flora Growth Corp. (NASDAQ:FLGC) Might Not Be As Mispriced As It Looks After Plunging 25%
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 25% in the...Flora Growth Corp.'s (NASDAQ:FLGC) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Flora Growth Corp. ( NASDAQ:FLGC ) shares have continued their recent momentum with a 28% gain in the last month alone...Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Today is shaping up negative for Flora Growth Corp. ( NASDAQ:FLGC ) shareholders, with the analysts delivering a...Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 27% over the previous 30 days, handing...Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 51% over the previous 30 days, handing...The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shares have had a really impressive month, gaining 41% after a shaky period...Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding
Flora Growth Corp. ( NASDAQ:FLGC ) shares have retraced a considerable 28% in the last month, reversing a fair amount...Desglose de ingresos y gastos
Cómo gana y gasta dinero ZeroStack. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 26 | 40 | -175 | 16 | 0 |
| 31 Mar 26 | 36 | -152 | 14 | 0 |
| 31 Dec 25 | 36 | -115 | 11 | 0 |
| 30 Sep 25 | 34 | -9 | 11 | 0 |
| 30 Jun 25 | 31 | -8 | 11 | 0 |
| 31 Mar 25 | 25 | -6 | 8 | 0 |
| 31 Dec 24 | 36 | -9 | 11 | 0 |
| 30 Sep 24 | 46 | -14 | 12 | 0 |
| 30 Jun 24 | 56 | -11 | 14 | 0 |
| 31 Mar 24 | 75 | -48 | 22 | 0 |
| 31 Dec 23 | 76 | -47 | 24 | 0 |
| 30 Sep 23 | 69 | -50 | 24 | 0 |
| 30 Jun 23 | 61 | -57 | 28 | 0 |
| 31 Mar 23 | 48 | -42 | 27 | 0 |
| 31 Dec 22 | 33 | -46 | 30 | 0 |
| 30 Sep 22 | 28 | -48 | 33 | 0 |
| 30 Jun 22 | 20 | -45 | 29 | 0 |
| 31 Mar 22 | 13 | -26 | 26 | 0 |
| 31 Dec 21 | 9 | -21 | 20 | 0 |
| 30 Sep 21 | 4 | -15 | 15 | 0 |
| 30 Jun 21 | 2 | -17 | 16 | 0 |
| 31 Mar 21 | 1 | -15 | 14 | 0 |
| 31 Dec 20 | 0 | -14 | 12 | 0 |
| 30 Jun 20 | 0 | -4 | 4 | 0 |
Ingresos de calidad: ZSTK actualmente no es rentable.
Margen de beneficios creciente: ZSTK actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ZSTK no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 30.4% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ZSTK en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: ZSTK no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare (20.8%).
Rentabilidad financiera
Alta ROE: ZSTK tiene una rentabilidad financiera negativa (-1265.05%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/08/20 11:15 |
| Precio de las acciones al final del día | 2026/08/20 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
ZeroStack Corp. está cubierta por 2 analistas. 1 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| William Kirk | Roth Capital Partners |